Non-Hodgkin Lymphoma — An Interview with Dr John P Leonard on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Research To Practice | Oncology Videos · May 10, 2025 · 52m

Featuring an interview with Dr John P Leonard, including the following topics:

First-line therapy for diffuse large B-cell lymphoma (DLBCL) with polatuzumab vedotin and R-CHP; impact of DLBCL cell of origin (0:00)

Epcoritamab, glofitamab and other bispecific antibodies as initial therapy for large B-cell lymphoma (9:27)

Sequencing chimeric antigen receptor T-cell therapy and bispecific antibodies for patients with relapsed/refractory (R/R) DLBCL (12:30)

Approved and investigational bispecific antibodies for the treatment of DLBCL (15:24)

Practical considerations for the administration of…